managing myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved therapeutic outcomes for patients diagnosed with multiple myeloma.
Global Rank: 1,991,926/ -213,530
Country Rank: 800,209/ +1,761,338
Country: USA
Category Rank: 2,218/ +2,870
Category: health/health conditions and concerns
Domain: Created by GoDaddy.com, LLC in 2008-07-24
  • Total Visits

    11.6K

  • Bounce Rate

    15.66%

  • Pages per Visit

    5.0

  • Avg Visit Duration

    00:04:16

managingmyeloma.com Ranking
Check if your rankings have improved or worsened over time. Over the last three months, managingmyeloma.com's global ranking has increased from 8,018,512 to 1,991,926.
managingmyeloma.com Traffic and Engagement
Website engagement metrics measure how much your website visitors are interacting with your website and online brand. managingmyeloma.com's traffic has decreased by -18.2% compared to last month.
Traffic & Engagement Last Month
Total Visits
11.6K
Last Month Change
-18.2%
Avg Visit Duration
00:04:16
Bounce Rate
15.66%
Pages per Visit
5.0
managingmyeloma.com Webpage Information
Page Title: Home
Keywords: abnormal acute renal failure adverse effects adverse events agent Alkeran allogeneic American Society for Blood and Marrow Transplantation American Society of Clinical Oncology American Society of Hematology amyloidosis anticoagulant Antonio Palumbo Aredia ASCO ASH aspirin asymptomatic autologous stem cell transplant Bence-Jones best practice beta 2 microglobulin biopsy bisphosphonate Blade response criteria blood bone bone density bone disease bone marrow bone pain bone survey bortezomib bortezomib resistance calcium cancer carfilzomib Center for Disease Control chemotherapy chromosome clinical practice clinical study clinical trial complete remission complete response compression fracture conditioning regimen consolidation control creatinine creatinine clearance cyclophosphamide cytogenetics cytotoxic Decadron deep vein thrombosis deletion denosumab dexamethasone diagnosis disease dose dose modification dose reduction dose-limiting Doxil doxorubicin drug drug resistance drugs duration of response Durie Salmon Eastern Cooperative Oncology Group education elderly eligible enoxaparin European Group for Blood and Marrow Transplantation evidence extramedullary failure first line fluorescence in situ hybridization fractures free light chain genetics guidelines hematologist hematology heparin herbal high risk history hypercalcemia IFM imaging IMF IMiDs immunofixation immunoglobulins immunohistochemistry immunomodulatory drugs IMWG IMWG criteria incidence induction International Bone Marrow Transplant Registry International Myeloma Foundation International Myeloma Working Group International Staging System ISS Staging System Journal of Clinical Oncology kidney disease kidney failure kyphoplasty lenalidomide lytic lesions M component m protein M spike maintenance therapy management Mayo Clinic melphalan MGUS microglobulin MMRC MMRF mobilization monoclonal gammopathy Mozobil multiple myeloma Multiple Myeloma Research Foundation myeloma myeloma treatment resources National Comprehensive Cancer Network NCCN neuropathic neuropathy neutropenia neutropenic new nonsecretory myeloma novel nurse nursing oncology oncologist oncology nurse society osteolytic osteonecrosis osteonecrosis of the jaw overall response rate overall survival pain pamidronate paraprotein partial response pegylated doxorubicin perifosine peripheral neuropathy pharmacy pharmacist physician plasma cell plasma cell disorder plasmacytomas plasmacytosis Plerixafor pomalidomide prednisone prevention prognosis prognostic factors progression progression free survival progressive proteasome inhibitor proteinuria pulmonary embolism QoL rate reduced intensity referral refractory relapsed remission renal residual disease response response criteria reversal Revlimid risk risk factors risk stratification safety serum albumin serum creatinine serum free light chains serum monoclonal M protein serum monoclonal protein side effects skeletal related events smoldering myeloma Southwest Oncology Group staging stem cell collection stem cell mobilization stem cell transplant survival rate study symptomatic thalidomide Thalomid therapeutic thrombocytopenia thromboembolism time to progression time to response toxicity translocation transplantation treatment treatment goals treatments urine protein electrophoresis Velcade venous thromboembolism very good partial response VTE zoledronic acid zoledronate Zometa Kenneth Anderson Paul Richardson Ann Mohrbacher Sagar Lonial Sergio Giralt Rafael Fonseca Carol Viele Kena Miller Beth Faiman Sundar Jagannath William Bensinger Robert Orlowski Rubern Nievisky Shaji K. Kumar Jean-Luc Harousseau How to treat multiple myeloma How to treat myeloma How to stage multiple myeloma How do I stage multiple myeloma? How do I stage myeloma? side effects of multiple myeloma treatments myeloma cardiac issues relapsed myeloma multiple myeloma treatment multiple myeloma staging multiple myeloma ISS Staging creatinine clearance and dose adjustment multiple myeloma drugs multiple myeloma risk stratification multiple myeloma response assessment Multiple Myeloma Differential Diagnosis Multiple Myeloma Differential Diagnoses
h1: 0
h2: 0
img: 24
script: 19
managingmyeloma.com Audience Demographics
Understanding social media demographics will help you fine-tune your marketing strategy and reach the right people with your message. managingmyeloma.com's audience is 58.06% male and 41.94% female. The largest age group of visitors are 25-34 year olds.
Similar Sites And managingmyeloma.com Competitors
Competitive Analysis is a foundation of digital marketing. If you know who your biggest competitors are, you can gather insights into what they do well and build your own strategy to outperform theirs. themmrf.org is the website with the highest similarity score to managingmyeloma.com.
managingmyeloma.com Traffic Sources Overview
Your website traffic data will show you where your traffic is coming from, how visitors engage with your site, and what digital marketing strategies are working. The main traffic sources for managingmyeloma.comare - and . An underutilized channel is "-".
managingmyeloma.com Top Keywords by Traffic Share
No Data to Display
Social Media Traffic to managingmyeloma.com
No Data to Display
managingmyeloma.com Referral Traffic & Outgoing Links
Referral Traffic
Sites that Referral traffic to managingmyeloma.com
GG
Outgoing Links
Sites that receive outbound traffic from managingmyeloma.com

    No Data to Display

managingmyeloma.com Geography & Country Targeting
For many businesses, it makes sense to target traffic from specific countries. Last month USA was the top country sending desktop traffic to managingmyeloma.com.
ADS
managingmyeloma.com Audience Interests
Identifying your target audience is the foundation of your marketing strategy. This helps you to understand who your target customer is and what they care about. managingmyeloma.com's audience is interested in - and -.
Top Categories

No Data to Display

Other Visited Websites

    No Data to Display

Top Topics

No Data to Display

Technology Stack
Instantly discover the technology stack used by any prospect or competitor to understand how their website works, which CMS or eCommerce platform they use, their communication tools of choice as well as analytics, hosting, advertising or internet technology usage.

Google Adsense

Google Analytics

About managingmyeloma.com data description

We aim to get you a complete analysis of managingmyeloma.com. Get a full overview of managingmyeloma.com and its online visibility. Analyze managingmyeloma.com’s growth trend over time. Effortlessly Analyze Your Competitive Landscape. We will update managingmyeloma.com's data regularly to ensure you have the latest information.

ads